Literature DB >> 6754412

Normal human serum contains a factor(s) capable of inhibiting megakaryocyte colony formation.

W Vainchenker, J Chapman, J F Deschamps, G Vinci, J Bouguet, M Titeux, J Breton-Gorius.   

Abstract

Growth of megakaryocyte colonies from human bone marrow progenitors has been achieved in plasma clot culture. Megakaryocyte colonies were identified either by cytological examination or by immunofluorescent labelling using a monoclonal antiplatelet antibody (J 15). No significant differences were observed in the quantitation of the colonies by these two methods. In the absence of a stimulating factor, MK colonies were detectable when high cellular concentrations were seeded. Among the numerous conditioned media tested for their ability to stimulate MK colony formation, conditioned medium from leukocytes stimulated by PHA (PHA-LCM) was the most effective. However, under standard conditions of culture corresponding to 20% normal human sera, colony formation was not related linearly to seeding density even when cultures were stimulated by PHA-LCM. Upon reduction of the concentration of serum (2.5-5%) in the culture medium, colony formation displayed a linear relationship seeding density only when PHA-LCM was used as the stimulating factor. At the same time, the size of the colonies increased. Such inhibition was observed with all the human sera tested but it varied in extent from one batch to another. Replacement of serum by albumin, iron-saturated transferrin, alpha-thioglycerol and low density lipoproteins at physiological concentration but in the presence of bovine plasma provided a culture system whose ability to support colony formation equalled that of low concentrations of whole serum; spontaneous MK colony formation still occurred. Our results provide evidence for the presence of an inhibitor(s) of MK colony formation in normal human sera, and demonstrate the role of cellular factors in stimulating MK colony formation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6754412

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  8 in total

1.  Kinetics of megakaryocyte progenitor cells in idiopathic thrombocytopenic purpura.

Authors:  K Dan; S Gomi; T Nomura
Journal:  Blut       Date:  1990-11

2.  Studies of human megakaryocytopoiesis using an anti-megakaryocyte colony-stimulating factor antiserum.

Authors:  H H Yang; E Bruno; R Hoffman
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

3.  Immunocytochemical identification of murine and human megakaryocyte colonies in soft-agar cultures.

Authors:  J L Zhang; P E Stenberg; G Baker; J Levin
Journal:  Histochem J       Date:  1994-02

4.  Purification and partial characterization of a megakaryocyte colony-stimulating factor from human plasma.

Authors:  R Hoffman; H H Yang; E Bruno; J E Straneva
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

5.  Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide.

Authors:  A M Gewirtz; B Calabretta; B Rucinski; S Niewiarowski; W Y Xu
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

6.  Human megakaryocytic progenitor cells.

Authors:  L Kanz; G W Löhr; A A Fauser
Journal:  Klin Wochenschr       Date:  1987-04-01

7.  Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production.

Authors:  Swapna Panuganti; Alaina C Schlinker; Paul F Lindholm; Eleftherios T Papoutsakis; William M Miller
Journal:  Tissue Eng Part A       Date:  2013-01-14       Impact factor: 3.845

8.  Alteration of vimentin intermediate filament expression during differentiation of human hemopoietic cells.

Authors:  K Dellagi; W Vainchenker; G Vinci; D Paulin; J C Brouet
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.